Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) (“Coeptis” or “the Company”), a biopharmaceutical company developing innovative cell therapy...
Oncology
The U.S. Food and Drug Administration (FDA) has granted approval for EntroGen’s CRCdx® RAS Mutation Detection Kit...
Henlius’ Novel Anti-PD-1 mAb HANSIZHUANG (Serplulimab) Approved for the Treatment of ESCC
2 min read
Shanghai Henlius Biotech, Inc. (2696. HK) announced that the new drug application (NDA) for new indication of...
Astellas Pharma Inc. (TSE:4503, President and CEO: Naoki Okamura, “Astellas”) and Seagen Inc. (Nasdaq: SGEN) today announced...
Antengene Corporation Limited (“Antengene” SEHK: 6996.HK), a leading commercial-stage innovative, global biopharmaceutical company dedicated to discovering, developing,...
Amgen (NASDAQ:AMGN) today announced exciting data from a study arm of the CodeBreaK 101 clinical trial, a...
Citius Pharmaceuticals, Inc. (“Citius” or the “Company”) (Nasdaq: CTXR), a late-stage biopharmaceutical company dedicated to the development...
Avenda Health, an AI healthcare company creating the future of personalized prostate cancer care, today announced its...
Wockhardt Hospitals, Mumbai Central in association with Specialty Surgical Oncology, Mumbai has launched Cancer Care Centre. Considering...
Program partners Pfizer Limited, Atal Innovation Mission (AIM), NITI Aayog, Social Alpha, Foundation for Innovation and Technology...